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Abstract
The AP-1 family transcription factor ATF2 is essential for development and tissue maintenance in mammals. In particular,
ATF2 is highly expressed and activated in the brain and previous studies using mouse knockouts have confirmed its
requirement in the cerebellum as well as in vestibular sense organs. Here we present the analysis of the requirement for
ATF2 in CNS development in mouse embryos, specifically in the brainstem. We discovered that neuron-specific inactivation
of ATF2 leads to significant loss of motoneurons of the hypoglossal, abducens and facial nuclei. While the generation of
ATF2 mutant motoneurons appears normal during early development, they undergo caspase-dependent and independent
cell death during later embryonic and foetal stages. The loss of these motoneurons correlates with increased levels of stress
activated MAP kinases, JNK and p38, as well as aberrant accumulation of phosphorylated neurofilament proteins, NF-H and
NF-M, known substrates for these kinases. This, together with other neuropathological phenotypes, including aberrant
vacuolisation and lipid accumulation, indicates that deficiency in ATF2 leads to neurodegeneration of subsets of somatic
and visceral motoneurons of the brainstem. It also confirms that ATF2 has a critical role in limiting the activities of stress
kinases JNK and p38 which are potent inducers of cell death in the CNS.
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Introduction
ATF2 belongs to the leucine-zipper domain-containing CREB/
ATF transcription factor family. It binds DNA as a homodimer on
calcium/cAMP response element (CRE) sequences or as a
heterodimer with structurally related AP-1 proteins, such as c-
Jun, to control the expression of a variety of target genes [1].
ATF2 is a substrate for MAP kinases, including c-Jun N-terminal
kinase (JNK), p38 kinase and p44/p42 MAPK (ERK1/2) [2,3,4].
MAPK phosphorylation of two threonine (Thr) residues, Thr69
and Thr71, is required for transcriptional activation of ATF2
[4,5]. One major role of ATF2 is to regulate the response of cells
to stress signals and JNK- and p38-mediated phosphorylation of
ATF2 is a key process for this response [6,7,8,9]. ATF2 has also
been shown to be phosphorylated by ATM kinase in response to
DNA damage [10].
ATF2 mutant mice generated by different gene targeting
approaches have demonstrated the importance of ATF2 for tissue
development and integrity and for postnatal viability. A hypo-
morphic ATF2 mouse mutant uncovered a variety of develop-
mental abnormalities, leading to defects in endochondral ossifica-
tion as well as defects in the nervous system. The latter include
ataxia, a reduced number of cerebellar Purkinje cells, atrophic
vestibular sense organs and enlarged ventricles, demonstrating the
importance of ATF2 for the coordinated development of the
mammalian brain [11]. A transcriptional null ATF2 mouse
mutant line is lethal at birth due to severe respiratory distress
resembling the human meconium aspiration syndrome [12].
Furthermore, a knock-in mutant line in which the Thr69 and
Thr71 phosphorylation sites are mutated into alanines (Atf2AA)
leads to a similar phenotype and to invariable death at birth,
confirming the importance of these phosphorylation sites for ATF2
activity [13].
In the nervous system, the role of ATF2 and of its binding
partner c-Jun in neurodegenerative stimuli-induced cell death has
been extensively studied in vivo. Phosphorylation of ATF2 at Thr71
was shown to occur during reperfusion following transient cerebral
ischemia in rat CA1 hippocampal neurons that were irreversibly
damaged [14]. In addition, expression and activation of c-Jun was
shown to have a significant role in neural development as well as in
a number of different neuronal pathologies [15]. Although ATF2
can regulate the expression of the c-Jun gene, substantial evidence
suggests that ATF2 and c-Jun have different roles in neuronal cells.
ATF2 is highly expressed in neurons of the adult rat nervous
system except for those neuronal populations which exhibit a high
basal level of c-Jun, such as the dentate gyrus, the red nucleus and
some cranial and spinal cord motoneurons (i.e. hypoglossal, facial,
oculomotor and sciatic nuclei) [16]. Following transection of
peripheral or central nerve fibres, such as the optic nerve or the
vagal and facial nerve fibres, ATF2 levels rapidly decreased in the
axotomised neurons during the period in which c-Jun expression
was rapidly increased [16]. ATF2 expression is also rapidly
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suppressed following ischemia and after mechanical injury during
the process of degeneration [17]. These results indicate that the
interplay between ATF2 and c-Jun activities is uncoupled in
neuronal cells. To understand in more detail the role of ATF2 in
neuron survival, we generated a neural cell-specific, conditional
mouse mutant for ATF2. We show that specific deletion of ATF2
in neurons leads to death after birth with similar phenotypic
appearances as the knockout germ line mutation. In these mutant
mice we find severe developmental defects in essential motoneu-
rons of the hindbrain with impact on respiratory regulation, an
observation which underlines the phenotypic abnormalities seen at
birth.
Results
Lack of functional ATF2 impairs proper development of
specific regions in the hindbrain
To produce a neuronal cell-specific ATF2 deletion, we crossed
nestin-Cre mice with mice expressing a floxed allele of Atf2 (Atf2f/f,
see Materials and Methods). Nestin-Cre induced recombination has
been shown to be efficient and tissue specific from early stages of
CNS development [18]. The crosses led to the effective deletion of
the DNA binding domain of ATF2 as normal ATF2 protein was
no longer detected in E18.5 brain of Atf2f/f;nestin-Cre mice
(Atf2Dneuron) (Figure S1A). Surprisingly, no adult Atf2Dneuron animals
emerged, suggesting that neuronal loss of ATF2 is lethal. We then
analysed when the lethality occurred and found that Atf2Dneuron
embryos were born at the expected frequency. However, the
mutant newborns were cyanotic and in respiratory distress, and
invariably died shortly after birth (Table 1). This phenotype was
very reminiscent of a previous finding of early postnatal death of
Atf22/2 mice [13]. Our findings suggest that the underlying defect
for this lethality was situated within the CNS while the early
postnatal death observed by Maekawa et al. (1999) was attributed
to defects in placental functions leading to stress-induced
meconium aspiration during the birth process. To clarify this,
we generated an additional conditional knockout using meox2-Cre
as the driver [19] resulting in ATF2 deleted in the epiblast and
subsequently in all embryonic tissues except for the placenta
Atf2Depiblast). Like Atf2Dneuron and Atf22/2 mice, the Atf2Depiblast
mutation also led to early postnatal death suggesting that the loss
of ATF2 dependent phenotypes cannot be attributed to placental
defects but rather to embryonic and primarily neuronal defects.
We then compared the phenotypic appearance of brains from
Atf2+/+ with Atf22/2, phosphorylation deficient Atf2AA [13], and
Atf2Dneuron E18.5 embryos. Overall, whole brain weights appeared
similar between the different genotypes (data not shown). In
contrast, cerebelli of Atf22/2, Atf2AA and Atf2Dneuron embryos were
smaller and lacked the typical foliation and tripartite layering seen in
wild-type or heterozygous embryos (Figure 1C and Figure S1B and
data not shown). This phenotype may likely develop into the
cerebellum defect that has been described in adult hypomorphic
ATF2 knockouts that were viable after birth [11]. We then
examined the brainstem of control and mutant embryos. E18.5
brainstems of wild-type and heterozygous embryos were indistin-
guishable in all experiments that were done, so we considered ATF2
heterozygous as wild-types. The brainstem of both Atf22/2 and
Atf2AA E18.5 embryos appeared significantly smaller while the
neural tube, from the obex to the caudal end of the medulla, was
enlarged compared to control littermates (Figure 1A and B). We also
noticed that in the mutants, neurons in the inferior olive were
diffusely distributed and did not form the typical crescent shape seen
in heterozygous embryos (Figure 1A, arrows). Strikingly, in Atf22/2
brains, hypoglossal and facial motoneurons stained with the
motoneuron-specific markers choline acetyltransferase (ChAT),
and Islet-1 (Isl-1), were partly missing (Figure 1D and E) and
abducens motoneurons were completely absent (see below). In
contrast, and in accordance with a previous publication [20],
abnormal expression of tyrosine hydroxylase (TH) was observed at
different antero-posterior levels of the midbrain and hindbrain (data
not shown). TH and ChAT double immunofluorescence staining
revealed aberrant expression of TH in some, otherwise cholinergic,
Atf22/2 hypoglossal and dorsal vagal motoneurons (Figure 1F).
Furthermore, we found increased expression of the glial cell-specific
marker glial fibrillary acid protein (GFAP) in the mantle zone of
Atf22/2 brainstems indicative of astrogliosis (Figure 1G).
Hypoglossal and dorsal vagal motoneurons play an important
role in respiration and cardiac function [21] and their disruption
could explain the perinatal respiratory defects of ATF2 mutant
mice. We therefore concentrated on further analysis of embryonic
motoneuron defects. Hematoxylin and eosin (H&E) stained sections
of E18.5 Atf22/2 hypoglossal and dorsal vagal motoneurons
displayed ballooned perikarya with eccentrically positioned nuclei
(Figure 2A and B). This phenotype was reproduced in Atf2AA and
Atf2Dneuron embryos (Figure 2C), indicating that the loss of the
transcriptionally active form of ATF2 impairs proper development
of these neurons. Immunostaining against the cytoskeletal protein
neurofilament M (NF-M) demonstrated an abnormal accumulation
of neurofilament in the soma of mutant motoneurons (Figure 2D).
Moreover, accumulated neurofilaments were found to be hyperpho-
sphorylated in Atf22/2 hypoglossal and dorsal vagal motoneurons
as shown by staining for phospho-NF-H and phospho-NF-M
(Figure 2E and F). Neurofilament hyperphosphorylation has been
found in certain neurodegenerative diseases, including amyotrophic
lateral sclerosis, ALS [22]. In addition, in ALS as well as in other
neurodegenerative diseases, abnormal lipid metabolism has been
found [23]. Staining of Atf22/2 and Atf2+/2 brainstem sections with
the fat-soluble dye Sudan black B revealed an abnormal
accumulation of lipids in Atf22/2 hypoglossal neurons (Figure 2G).
Transmission electron microscopy on Atf22/2 brainstem sections
containing the hypoglossal nucleus revealed vacuoles accumulating
in cell bodies and surrounding neuropil (Figure 2H). These results
therefore suggest that neurodegeneration occurs in the hypoglossal
and dorsal vagal motoneurons of ATF2 mutant embryos.
Neural patterning and axonal growth is normal in Atf22/2
brainstem
To identify the causes leading to the cytological and morpholog-
ical defects of the Atf22/2 brainstem at E18.5, we analysed the
brainstem at earlier developmental stages. For this, we initially
focused on the generation of progenitor cells along the dorsoventral
Table 1. List of germline and tissue specific conditional ATF2
deletions.
Genotype Mutation Phenotype
Atf22/2 Germline deletion 100% lethality at birth
Atf2AA T51/T53 mutation Same as Atf22/2
Atf2Dneuron Atf2f/f;nestin-Cre Same as Atf22/2
Atf2Depiblast Atf2f/f;meox2-Cre Same as Atf22/2
Atf22/2 mutant mice were obtained as a result of Atf2+/2 x Atf2+/2 crosses.
Atf2AA were the result of Atf2+/AA x Atf2+/AA crosses. Atf2Dneuron and Atf2Depiblast
resulted from Atf2f/f x Atf2f/+;nestin-Cre and Atf2f/f x Atf2f/+;meox2-Cre crosses,
respectively. All animals were on a C57/Bl6 strain background. A minimum of 10
offspring litters were analysed for each knockout combination.
doi:10.1371/journal.pone.0019090.t001
Motoneuron Degeneration in ATF2 Knockout Mice
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axis at E10.5. The generation of these progenitor cells has been
thoroughly studied in vivo and involves a number of transcription
factors, including Pax6, Pax7, and Nkx2.2, which specify the
identity of several classes of neurons [24]. When we compared
ATF2 knockout and heterozygous embryos for the generation of
progenitor cells at E10.5, we did not observe any significant
differences in the expression patterns of these transcription factors
(Figure 3A). We then analysed the antero-posterior expression
pattern of two genes, Krox20 andHoxb3, known to play an important
role in caudal hindbrain segmentation [25,26]. Whole-mount in situ
hybridization did not reveal any differences in the expression
pattern of Krox20 and Hoxb3 between Atf22/2 and Atf2+/2
embryos (Figure 3B). Motoneurons also extended their axons
normally, as shown by embryo whole-mount immunostaining of
neurofilament M (NF-M) at E12.5 (Figure 3C). These results suggest
that ATF2 is not essential for motoneuron generation but is likely to
play a role later in development.
ATF2 is expressed in newly-born somatic and visceral
motoneurons of the brainstem
To understand ATF2 expression patterns in developing
motoneurons, we stained brainstem sections for ATF2 at E11.5–
E12.5. For this we used antibodies directed against its DNA-
binding domain (ATF2-DBD) as well as antibodies that recognize
phosphorylated ATF2 at Thr71 (ATF2-PT71). Both of these
antibodies were highly specific for their respective epitopes as
Figure 1. Histological abnormalities in E18.5 ATF2 mutant cerebellum and brainstem. (A) Hematoxylin and eosin (H&E) stained transversal
sections of brainstem at the level of the inferior olive. Atf22/2 and Atf2AA brainstems are significantly smaller and have an enlarged central canal
compared to Atf2+/2. The inferior olive (arrow) is severely underdeveloped in mutant embryos. Bar: 250 mm. (B) Area plot of the central canal (mean6
SEM of 3 brainstems analysed per genotype), measured along the antero-posterior axis of serial transversal sections from the obex (0 mm on the x-
axis) posteriorly to the caudal end of the medulla, shows a significant enlargement of the canal in Atf22/2 embryos. (C) Horseradish peroxidase (HRP)
immunostaining of calbindin in sagittal sections of the cerebellum. Atf22/2 cerebellum lacks the foliation and the tripartite layering seen in Atf2+/2
cerebellum. Bar: 250 mm. (D) HRP immunostaining of choline acetyltransferase (ChAT) in transversal sections of Atf22/2 and Atf2+/2 posterior medulla.
Number of hypoglossal motoneurons (h) is bilaterally decreased in Atf22/2 embryos while number of dorsal vagal motoneurons (v) appears normal.
This was seen at several levels along the longitudinal axis. Bar: 200 mm. (E) HRP immunostaining of Islet-1 (Isl-1) in transversal sections of Atf22/2 and
Atf2+/2 anterior medulla. A severe reduction in the number of motoneurons is found in the Atf22/2 facial nucleus (f). Bar: 100 mm. (F) Double
immunofluorescence staining of TH (green) and ChAT (red) shows aberrant expression of TH in hypoglossal (h) and dorsal vagal (v) motoneurons in
Atf22/2 brains. Bar: 50 mm. (G) GFAP immunostaining (red) reveals aberrant expression of GFAP in the mantle zone of Atf22/2 brainstem. Bar: 50 mm.
doi:10.1371/journal.pone.0019090.g001
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Figure 2. Neuropathological lesions in E18.5 ATF2 mutant motoneurons. (A, B) H&E stained transversal sections of Atf22/2 and Atf2+/2
posterior medulla. Atf22/2 hypoglossal (h) and dorsal vagal (v) motoneurons show ballooned perikarya with eccentrically positioned nuclei
(arrowheads). Insets: magnification of dorsal vagal motoneurons. (C) H&E staining of Atf2Dneuron hypoglossal and Atf2AA vagal motoneurons showing
the same pathological lesions (arrowheads). (D–F) HRP immunostaining with antibodies against neurofilament M (NF-M), phospho-neurofilament H
(P-NF-H, RMO24.9) and phospho-neurofilament M (P-NF-M, RMO8) in Atf22/2 and Atf2+/2 posterior medulla. Aberrant NF-M accumulation in the soma
of Atf22/2 dorsal vagal and hypoglossal motoneurons is indicated by arrowheads. P-NF-H and P-NF-M are predominantly present in Atf22/2
motoneurons. Insets: magnification of NF-M stained hypoglossal motoneurons. (G) Sudan black B staining shows lipid accumulation in Atf22/2 but
not in Atf2+/2 hypoglossal motoneurons. Bars: A–G, 100 mm; insets, 25 mm.(H) Transmission electron microscopy photograph of Atf22/2 brainstem
shows a lipid droplet near a cell (asterisk), and a cytoplasmic vacuole filled with neurofibrillary material (arrow). Bar: 2 mm.
doi:10.1371/journal.pone.0019090.g002
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shown in Figure S2. This analysis revealed that ATF2 is robustly
expressed in the majority of motoneurons that were identified by
co-staining with the motoneuron-specific marker Isl-1. Specifically,
ATF2 as well as phosphorylated ATF2 were detected in
hypoglossal, dorsal vagal and abducens motoneurons at E12.5
(Figure 4A and A’, 4B and B’, 4E and E’) and in facial
branchiomotor neurons at E11.5 (Figure 4C and C’). We did
not find significant expression of ATF2 or ATF2-PT71 in other
neurons of the brainstem at these developmental stages (data not
shown). Interestingly, ATF2-PT71 is also observed in motoneu-
rons of the spinal cord at the C1 level (Figure 4D and D’),
suggesting that ATF2 may play a role in the spinal cord, in
addition to the brainstem. These results show that ATF2 is
specifically expressed, between E11.5 and E12.5, in all visceral and
somatic motoneurons we examined and may thus play a role in the
further differentiation of these neurons.
Survival of hypoglossal and abducens motoneurons is
dependent on ATF2 expression
We next investigated the importance of ATF2 in later
motoneuron development. Since we have previously found a
reduction in hypoglossal motoneurons at E18.5, we examined the
specification and further development of these motoneurons in
Atf2+/2 and Atf22/2 embryos. For this we stained serial transversal
sections of rhombomere 7 with the postmitotic marker Isl-1 and
counted the number of Isl-1+ hypoglossal neurons present at E12.5
and E14.5. This staining and, in addition, staining of motoneurons
with 5-HT (see Materials and Methods for quantification) at E18.5
revealed a significant and progressive loss of hypoglossal
motoneurons in ATF2 mutant embryos (Figure 5A and B). At
E12.5, motoneurons of the abducens nucleus appeared to be
entirely absent in Atf22/2 embryos (Figure 5D), although they
were normally produced in rhombomere 5 at E10.5 (Figure 5C).
One possibility is that the loss of these neurons was caused by
increased apoptosis. Immunostaining with the apoptotic marker
Cleaved Caspase 3 revealed a significant increase in apoptotic
bodies in Atf22/2 compared to Atf2+/+ abducens motoneurons
(Figure 5E and F). However, in contrast, no significant increase in
Caspase dependent, apoptotic cell death was detected in
hypoglossal motoneurons (data not shown). These results suggest
that ATF2 has a strong pro-survival role, and its absence leads to
Caspase 3 dependent cell death at least in early-born abducens
Figure 3. Dorso-ventral (D–V) and antero-posterior (A–P) patterning is normal in Atf22/2 brainstem at E10.5. (A) Double
immunofluorescence staining for class III b-tubulin (Tuj1, red) and for neuronal class progenitor cells markers Nkx2.2, Pax6, Pax7 (all green) and
postmitotic marker Isl-1 (green) in Atf22/2 and Atf2+/2 brainstem. No significant difference was observed in the expression domains of the
transcription factors between the two genotypes. Bar: 100 mm. (B) Whole-mount in situ hybridization for Krox20 and Hoxb3. No differences were
observed in the expression domain between the two genotypes. r4, r5, rhombomere 4 and 5. Note that, at this stage, Krox20 expression is seen in
rhombomere 5 (r5) only. (C) Atf22/2 and Atf2+/2 whole-mount immunostaining with NF-M antibody at E12.5. Fiber nerves extend normally from
Atf22/2 hypoglossal (XII) and vagal (X) nuclei. C1, C2, first and second cervical nerve, XII, hypoglossal nerve, X, IX, vagal and glossopharyngeal nerves,
VII, VIII, acousticofacial nerve, V3, mandibular nerve, V2, maxillary nerve, V1, ophthalmic nerve.
doi:10.1371/journal.pone.0019090.g003
Motoneuron Degeneration in ATF2 Knockout Mice
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19090
neurons. However, the gradual disappearance of Atf22/2
hypoglossal neurons appears to be independent of Caspase 3
activity.
Atf22/2 somatic and visceral motoneurons express
hyperphosphorylated JNK and c-Jun
To understand the mechanism by which cell death is induced in
Atf22/2 hypoglossal motoneurons, we analysed signaling pathways
that could be involved. Activation of the stress activated MAP
kinase JNK and of its target substrate c-Jun are important
mediators of neuronal stress response after cerebral ischemia and
central nerve fiber tract transection [27]. Enhanced c-Jun
expression also occurs in neurodegeneration disorders [28]. We
therefore investigated whether ATF2 could regulate the activation
of stress activated kinases in motoneurons. Staining with
antibodies against phosphorylated (Thr183/Tyr185) JNK revealed
that P-JNK was significantly increased in hypoglossal and dorsal
vagal Atf22/2 motoneurons at E12.5 compared to Atf2+/2
motoneurons (Figure 6A and B). Enhanced phosphorylation of
JNK was also detected in Atf22/2 facial branchiomotor neurons
(Figure S3E and F) and in Atf22/2 motoneurons of the spinal cord
at the C1 level (Figure S3I-L). JNK hyperphosphorylation in
Atf22/2 was also maintained at later stages in hypoglossal and
vagal motoneurons at E14.5 (Figure 6C and D). Importantly, JNK
phosphorylation was also increased in hypoglossal and vagal
motoneurons of Atf2AA embryos, similar to the results observed in
ATF2 knockout brainstems (Figure S3A–D). Interestingly, while
levels of P-p38 (Thr180/Tyr182) were very low in both knockouts
and heterozygotes at E12.5 (Figure 6E and F), at E14.5 a
significant increase in the phosphorylation of p38 was detected in
Atf22/2 motoneurons but not in controls (Figure 6G and H). No
significant differences were found in the phosphorylation status of
ERK1/2 at E12.5 or E14.5 (Figure S3M-P).
Subsequently we performed Western blot analysis of extracts
derived from hindbrain regions of E14.5 embryos. These
confirmed that both P-JNK and P-p38 were up-regulated in
Atf22/2 samples compared to controls (Figure 7A). In addition we
found significantly increased levels of BimEL and P-Bcl2 (Ser70)
(Figure 7B). The phosphorylation of Ser70 leads to inactivation of
Bcl2 and promotes apoptosis. This result is therefore consistent
with the observed increased apoptosis in mutant neurons.
ATF2 regulates the expression of c-Jun and dual
specificity phosphatase genes
Since c-Jun is a substrate of JNK activity it is conceivable that
high levels of P-JNK would also lead to increased levels of
phosphorylated c-Jun. Indeed, phosphorylation of c-Jun at Ser73
was found significantly increased in Atf22/2 hypoglossal neurons
at E12.5 and E14.5 (Figure 6I-L) as well as in facial
branchiomotor neurons (Figure S3G and H). While phosphory-
lation of c-Jun was strongest in cranial nerve nuclei, enhanced
phosphorylation was also observed in many cells in the mantle
zone at E14.5 (Figure 6K, arrowheads, and data not shown).
Therefore ATF2 is essential to regulate c-Jun activity in
developing motoneurons possibly through restricting the activities
of JNK. ATF2 can also regulate the expression of c-Jun. To test
whether this is the case in neurons of the brainstem we immuno-
stained sections for pan-c-Jun. At E12.5, comparable expression
Figure 4. ATF2 expression in somatic and visceral motoneurons at E11.5 and E12.5. (A–D) Fluorescence immunostaining for
phosphorylated ATF2 (ATF2-PT71, red). (A’–D’) Double immunofluorescence staining for phosphorylated ATF2 (red) and postmitotic marker Isl-1
(green). Phosphorylated ATF2 is robustly detected in E12.5 hypoglossal (h) and dorsal vagal (v) motoneurons (A, A’), in E12.5 abducens (abd)
motoneurons (B, B’, arrowheads) and in facial branchiomotor neurons (C, C’) at E11.5. In addition phospho-ATF2 is also detected in C1 motoneurons
of the spinal cord at E13.5 (D, D’, arrowheads). Little or no expression of phosphorylated ATF2 is found in the surrounding cells or on the dorsal side of
the brainstem at this stage. Bar: 100 mm. (E, E’) E12.5 hypoglossal (h) and dorsal vagal (v) motoneurons express ATF2 as shown by immunostaining
with ATF2-DBD antibody (red) and Isl-1 (green). r4, r5, r7, rhombomere, 4, 5, and 7.
doi:10.1371/journal.pone.0019090.g004
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patterns of c-Jun were observed between Atf22/2 and Atf2+/2
hypoglossal neurons (Figure 6M and N). However, at E14.5, c-
Jun expression was significantly decreased in Atf22/2 hypoglossal
neurons compared to heterozygous control embryos, while
retaining strong expression in some neurons of the vagal nuclei
which were otherwise negative for Isl-1 (Figure 6O and P). From
these results we concluded that c-Jun has a complex expression
pattern in developing motoneurons, and is, at least, partly under
ATF2 transcriptional regulation.
To confirm that c-Jun dependence on ATF2 is at the level of
mRNA expression we isolated RNA, using laser capture micro-
dissection, from regions of the hindbrain of E14.5 embryos that
correlated with high Isl-1 expression. Quantitative mRNA analysis
revealed significant loss of c-Jun mRNA in Atf22/2 neurons
Figure 5. Somatic motoneuron defects in Atf22/2 embryos. (A) Isl-1 immunostaining (red) of Atf22/2 and Atf2+/2 hypoglossal motoneurons at
E14.5 reveal the reduction of Isl-1 positive hypoglossal motoneurons in Atf22/2 embryos. (B) Quantitative analysis of hypoglossal motoneurons (mean
number per section 6 SD) in serial transversal sections of rhombomere 7 (r7) by Isl-1 immunostaining for E12.5 and E14.5 embryos or by 5-HT
immunostaining and hematoxylin counterstaining for E18.5 embryos. Student’s two-tailed t-Test, *, p = 0.04; ***, p,0.01; ***; p,0.001. (C)
Coimmunostaining of abducens motoneurons with Isl-1 (red) and Lim3 (green) antibodies reveals normal production of these motoneurons in
Atf22/2 mice at E10.5 in r5. V2 IN, V2 interneurons, abd, abducens motoneurons, SSM, superior salivatory motoneurons. (D) Complete loss of
abducens motoneurons (abd) in Atf22/2 E12.5 embryos as revealed by Isl-1 (red) immunostaining. fbm, facial branchiomotor neurons. (E)
Coimmunostaining of abducens motoneurons with Cleaved Caspase 3 (CC3, red) and Lim3 (green) antibodies reveals increased apoptosis in Atf22/2
motoneurons at E11.5. Lim3 strongly labels V2 interneurons and more weakly abducens motoneurons. Bar: 100 mm. (F) Quantitative analysis of
apoptotic bodies (mean number per section 6 SD) in serial transversal sections of rhombomere 5 at E11.5 reveals increased apoptosis of abducens
neurons in Atf22/2 embryos. ***, p,0.01.
doi:10.1371/journal.pone.0019090.g005
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(Figure 8A). This observation was also confirmed by RNA in situ
hybridization using a c-Jun antisense mRNA probe (Figure S4)
and by Western blot which shows a decrease in c-Jun present in
mutant neurons (Figure 8B).
In addition to c-Jun we also analysed the expression of genes
encoding dual specificity phosphatases, which have been shown
previously to be targets of ATF2 in the embryonic liver. We found
reduced expression of Dusp1, Dusp8, and Dusp10 in Atf22/2
neurons whereas other Dusp genes, e.g. Dusp4 and Dusp6 (data
not shown) showed similar expression levels between wild-types
and knockouts (Figure 6A). Reduced expression of MKP1 (the
gene product of Dusp1) and MKP5 (the gene product of Dusp10)
was also confirmed by Western blot (Figure 8B). These data
therefore suggest that, in developing neurons, ATF2 is required for
the expression of specific phosphatases that can negatively regulate
the activities of JNK and p38.
Newly-born Atf22/2 motoneurons accumulate
neurofilament aggregates
JNK activity has been associated with cytoskeletal integrity [29].
Since significantly higher levels of P-JNK were detected in the
cytoplasm of ATF2 mutant motoneurons, we analysed the
neurofilament cytoskeleton in newly-born motoneurons. Immu-
nostaining with antibodies against NF-M and phospho-NF-M
revealed that the cell bodies of E12.5 Atf22/2 hypoglossal neurons
aberrantly accumulate NF-M compared to the more diffuse
pattern seen in Atf2+/2 (Figure 9A and C). At E12.5, phosphor-
ylated NF-M was not yet detected. We further show that NF-M
aggregates are also present in E14.5 Atf22/2 hypoglossal and vagal
motoneurons somas (Figure 9E and G). At this age, we also
detected phosphorylated NF-H strongly in Atf22/2 but only
weakly in Atf2+/2 motoneurons (Figure 9F and H). Accumulation
of NF-M as well as P-NF-H was also observed in the anterior horn
of Atf22/2 spinal cords at E15.5 (Figure 9I-L). These results
indicate that neurofilament cytoskeleton integrity is abnormal in
post-mitotic Atf22/2 motoneurons. This phenotype coincides with
the appearance of hyperphosphorylated JNK and p38. Hyper-
activation of the stress activated protein kinase pathways may
therefore be critical for motoneuron degeneration and other
pathological lesions observed at E18.5.
Discussion
Neuronal-specific ATF2 expression is required for
embryonic survival
The study presented here reveals novel, essential functions for
ATF2 in motoneuron integrity during mammalian development and
provides a mechanistic insight into the regulation of stress kinase
signaling in the central nervous system. Previous phenotypic studies
on ATF2 hypomorphic alleles indicated a range of neurological
abnormalities in the cerebellum as well as vestibular sense organs
[11] of adult mice. More recent analyses have also uncovered defects
Figure 6. Enhanced phosphorylation of JNK, p38, and c-Jun in Atf22/2 motoneurons. Double immunofluorescence staining of Isl-1 (A–P,
red) and phospho-JNK (Thr183/Tyr185, green, A–D), phospho-p38 (Thr180/Tyr182, green, E-H), phospho-c-Jun (Ser73, green, I-L) and pan-c-Jun
(green, M–P) in hypoglossal (h) and vagal (v) motoneurons at E12.5 and E14.5. (A–D) JNK is hyperphosphorylated in both motoneuron types in
Atf22/2 (A and C) compared to Atf2+/2 (B and D) embryos at E12.5 and E14.5. (E–H) Phosphorylation of p38 is hardly detectable in Atf2+/2 and Atf22/2
at E12.5 (E and F) but significantly increases at E14.5 in motoneurons of Atf22/2 (G) compared to Atf2+/2 embryos (H). (I-L) c-Jun is hyper-
phosphorylated in motoneurons of Atf22/2 (I and K) compared to Atf2+/2 (J and L) embryos at E12.5 and E14.5. Strong phosphorylation of c-Jun is
notable in hypoglossal and vagal motoneurons at E14.5 and there is a weaker but detectable phosphorylation signal in surrounding cells in Atf22/2
embryos (K, arrowheads). (M, N) High and moderate levels of c-Jun were observed in hypoglossal motoneurons but were indistinguishable between
Atf22/2 and Atf2+/2 embryos at E12.5. (O, P) At E14.5, Atf22/2 hypoglossal neurons tend to express c-Jun at lower levels than in Atf2+/2 neurons;
notably some strong c-Jun labeling was detected in some Isl-1 negative cells in Atf22/2. Bar: 100 mm.
doi:10.1371/journal.pone.0019090.g006
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in catecholaminergic neurons of the pons and the medulla [20].
Together these findings suggest a fundamental role for ATF2 in
neurological functions in adult mice. In the present work, we
demonstrate that ATF2 has much earlier roles in CNS development
and which become critical for survival at the end of foetal
development. To show this we developed neuronal specific ATF2
knockouts by crossing nestin-Cre transgenic with ATF2 floxed
animals. Surprisingly, the neural specific deletion of ATF2 resulted
in complete perinatal lethality due to respiratory defects, comparable
to the phenotype of the Atf22/2 or Atf2AA mutants. Therefore, an
early requirement of ATF2 in the central nervous system is critical
for postnatal viability. Previously, it has been suggested that the
lethality observed in Atf20/0 mice was a result of defective placenta
development [12]. However, the ATF2 mutants produced in our lab
do not support this notion. Firstly, analysis of Atf22/2 embryos and
newborns did not reveal any observable morphological defects in the
placenta [13]. Secondly, the meox2-Cre;Atf2f/f conditional allele of
ATF2 which targets the epiblast, but not the placenta, also leads to
perinatal lethality therefore excluding placental defects as an
underlying cause. Thirdly, the nestin-Cre;Atf2f/f derived conditional
allele of ATF2 phenocopies most if not all of the neuronal defects
that were uncovered in the Atf22/2 mutants.
Analysis of ATF2 mutant brains has revealed a number of
anatomical defects in the CNS. At E18.5, brainstem and the
cerebellum were significantly reduced in size. In addition, defects
in the laminar patterning of the cerebellum, and enlargement of
the central canal were apparent. In further detailed analyses we
found that several cranial motor nuclei were strongly affected in
mutant brainstems. In particular, cranial motoneurons of the
facial, hypoglossal, abducens and dorsal vagal nuclei were
significantly reduced in numbers or severely degenerated. Can
individual or combinations of these defects explain the early
postnatal respiratory disorder and death of ATF2 mutant mice?
Mouse knockouts of several transcription factors such as MafB,
Phox2a, Phox2b, Rnx, and Mash-1, have been shown to affect
different groups of respiratory neurons in the brainstem resulting
in respiratory phenotypes and death at or shortly after birth [30].
These phenotypes included loss of neurons in the (nor)adrenergic
and serotonergic centers [31], in the nucleus tract solitarius [32]
and in the prebo¨tzinger complex [33]. However, none of these
appear to affect cranial motoneurons. Cranial motoneurons
innervate muscles controlling airway dimensions and exhibit an
important rhythmic respiratory activity that is synchronous with
the activity of respiratory neurons of the medulla during expiration
and inspiration [34]. Importantly, in humans, hypoplasia of
several brainstem nuclei affected in our ATF2 mutant mice,
including the inferior olivary nuclei, the facial, the dorsal vagal and
the hypoglossal nuclei have been reported in cases of intrauterine
Figure 7. Up-regulation of P-JNK and P-p38 in Atf22/2 hindbrains. (A) Western blot analysis shows increased P-JNK (Thr183/Tyr185) and P-
p38 (Thr180/Tyr182) in Atf22/2 compared to Atf2+/+ E14.5 hindbrains extracts. (B) Expression levels of BimEL and P-Bcl2 (Ser70) are shown. Bar graphs
show relative signal intensity between Atf2+/+ (white bars) compared to Atf22/2 (black bars). Significance values (p) were determined from 3
independent samples using Student’s t-test.
doi:10.1371/journal.pone.0019090.g007
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or neonatal sudden death as well as in sudden infant death
syndrome [35]. Interestingly, cranial motoneuron nuclei hypo-
development is frequently associated with pulmonary hypoplasia
and aspiration pneumonia [35,36]. It is therefore plausible that the
brainstem malformation caused by ATF2 mutation leads to similar
respiratory defects to those seen in some forms of human sudden
death syndromes.
ATF2 has a strong pro-survival role in somatic
motoneurons of the brainstem
In order to explain the motoneuron phenotype observed at
E18.5, we sought to determine the earliest developmental events
for which neuronal ATF2 functions may be critical. At around
E10.5, neuronal progenitors receive positional information along
the anteroposterior and dorsoventral axes, and a number of
homeodomain proteins are key molecules for this specification
[37]. Notably, vagal motoneurons differentiate ventrally within a
domain in which progenitor cells express Nkx2.2, whereas
hypoglossal motoneurons differentiate dorsally within a domain
in which progenitors express Pax6 [38]. Several mouse knockouts
for these homeobox genes show changes in the fate of
motoneurons, alterations in the migratory behavior of motoneu-
rons, and defects in motor axon extension [24,39,40,41]. In
addition, gene inactivation of Krox20 and Hoxb3, which control the
assignment of specific rhombomere identities, both lead to the
Figure 8. Expression of ATF2 target genes in hindbrain motoneurons. Real-time quantitative PCR assays of laser micro-dissected tissue of
E14.5 hindbrains. Bar graphs show relative expression values between Atf2+/+ (white bars) and Atf22/2 (black bars) for Atf2, c-Jun, Dusp1, Dusp4,
Dusp8, and Dusp10 mRNAs. Significance values (p) were determined from 3 independent samples using Student’s t-test.
doi:10.1371/journal.pone.0019090.g008
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complete elimination of abducens motoneurons as well as defects
in other motoneuron populations [42,43]. While germ line
deletion of Hoxb3 results in viable animals, Krox20 mutant offspring
display significant respiratory defects and a large proportion die
within hours after birth [44,45]. At E10.5, dorsoventral patterning
proceeded normally in ATF2 mutants as judged by the expression
pattern of Nkx2.2, Isl-1, Pax6 and Pax7 which was similar to that
in heterozygotes. Krox20 and Hoxb3 were also both normally
expressed in the knockouts, suggesting that rhombomere 5 was
intact. We also show normal extension of the hypoglossal, dorsal
vagal and spinal cord motoneuron axons in ATF2 mutant
embryos. In addition, Isl-1 staining revealed that all major somatic
and viscerobranchiomotor neurons, including abducens, hypo-
glossal, trigeminal (data not shown), facial and dorsal vagal
motoneurons were produced. Therefore, ATF2 inactivation does
not appear to affect early anteroposterior and dorsoventral cell
specification.
ATF2 and phosphorylated ATF2 proteins are specifically and
robustly expressed in newly-born hypoglossal, dorsal vagal, facial
and abducens motoneurons between E11.5 and E12.5 as well as in
the spinal cord in C1 motoneurons at E13.5. This expression
pattern suggests a functional involvement of ATF2 in motoneuron
development. Indeed, inactive ATF2 leads to the complete loss of
abducens motoneurons at E11.5, as well as the gradual loss of
hypoglossal motoneurons between E12.5 and E18.5. At least in the
case of abducens motoneurons we could demonstrate that cell loss
is due to aberrant caspase- dependent apoptosis. In contrast, loss of
hypoglossal neurons appears to be Caspase 3-independent and it
remains to be seen which cell death mechanism is responsible.
These results however suggest that ATF2 is an important
suppressor of developmental cell death and its loss leads to
degeneration of somatic motoneurons.
Loss of functional ATF2 leads to hyperphosphorylated
JNK and p38, and results in somatic and visceral
motoneuron degeneration
In exploring a molecular mechanism underlying the observed
neurodegeneration we found that JNK and c-Jun were hyperpho-
sphorylated, and therefore, hyperactive in cranial motoneurons
from as early as E12.5, and p38 from E14.5. Lasting N-terminal
phosphorylation of c-Jun and JNK has been associated with
cerebral ischemia-reperfusion and nerve fiber transection [27]. In
addition, phosphorylation of c-Jun was shown to be required for
embryonic programmed cell death in motoneurons in mouse and
chick [46]. Furthermore, JNK dependent phosphorylation of c-Jun
Figure 9. Neurofilament M (NF-M) accumulation in Atf22/2 motoneurons. (A–D) Immunostaining against NF-M (A and C) and
phosphorylated NF-H (B and D) at E12.5 reveals strong accumulation of NF-M in the soma of Atf22/2 hypoglossal motoneurons (h) but not in Atf2+/2
motoneurons (compare A and C). Phosphorylation of NF-H as detected with the antibody RMO24.9 was not yet observed at this age. (E–H)
Immunostaining against NF-M (E and G) and phosphorylated NF-H (F and H) at E14.5 reveals strong accumulation of NF-M in hypoglossal (h) and
vagal (v) motoneurons in Atf22/2 (E) compared to Atf2+/2 embryos (G). Phosphorylation of NF-H can be detected in Atf22/2 motoneurons (F,
arrowheads) but not in Atf2+/2 neurons (H). Inset: magnification of P-NF-H stained hypoglossal neurons. (I-L) Immunostaining against NF-M (I and K)
and phosphorylated NF-H (J and L) at E15.5 reveals aberrant accumulation of NF-M and hyperphosphorylation of NF-H in the soma of Atf22/2 spinal
cord motoneurons at the C1 level (C1 mn) but not in Atf2+/2 neurons. Bar: 100 mm. Inset: magnification of P-NF-H stained C1 motoneurons. Bar:
25 mm.
doi:10.1371/journal.pone.0019090.g009
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is required for stress induced apoptosis in hippocampal and
cortical neurons [47]. It could therefore be possible that in ATF2
mutant embryos JNK-activated c-Jun leads to cell loss of
motoneurons by apoptosis. However, not all the neuronal cell
loss we observe is via caspase dependent apoptosis which c-Jun
may be capable of inducing. Furthermore, after crossing ATF2
mutant mice with c-Jun mutant mice which are deficient in
phosphorylaton by JNK [47] the early postnatal lethal phenotype
of the ATF2 single mutant prevailed (unpublished results),
suggesting that the observed neuronal cell death is probably
independent of JNK dependent c-Jun activation. Indeed, JNK has
been shown to phosphorylate a number of apoptotic regulators of
the Bcl2 family, including Bcl2 [48,49], Bclx(L) [50], and Bim
[51].
The observed high levels of active JNK, as well as p38, may
have roles in inducing neuronal cell death independent of c-Jun.
This possibility is emphasized by the higher cytoplasmic levels of
phospho-JNK observed in mutant motoneurons (see Figure 6).
The hyperphosphorylation of JNK, and p38, coincided with the
accumulation, and phosphorylation, of neurofilament proteins
specifically in motoneurons but not in other subpopulations of
neurons (e.g. interneurons, or sensory neurons). Studies in
neuroblastoma cells have shown that MAP kinase ERK is involved
in normal neurofilament NF-H phosphorylation whereas neuro-
toxin induced JNK activation leads to aberrant NF-H phosphor-
ylation and accumulation [52,53]. In addition, Ackerley et al. have
shown that p38a phosphorylates NF-M and NF-H on their side-
arm domains in cortical neurons, thereby modulating the
flexibility and stability of the cytoskeleton [29,54]. Abnormal
accumulations of neurofilaments with phosphorylated NF-H side
arms are pathological features of motoneuron diseases such as
amyotrophic lateral sclerosis (ALS). Particularly, enhanced p38
activation has been reported in motoneurons from transgenic mice
expressing ALS-linked SOD1 mutants [55,56,57] as well as in
human ALS patients [54].
In addition to abnormal accumulation and phosphorylation of
neurofilaments in cell bodies and proximal axons we observed
other histopathological features of motoneuron degeneration,
including ballooned perikarya and vacuolization. Vacuolization
is a further prominent feature of the ALS-model SOD1 mutant
mice [58]. Results in our mutants show that these vacuoles may
primarily contain lipids as revealed by Sudan black B staining.
This coincides with increasing evidence of abnormalities in lipid
metabolism in ALS patients and lipids observed in SOD1 mutant
neurons [23,59]. In other studies of ALS linked SOD1 mutant
mice activated JNK has also been observed [60]. In addition,
pathological roles for JNK activation have been well documented
in other neurodegenerative disorders such as Parkinson’s disease
and Alzheimer’s disease [61,62].
From our study, it is not yet clear how ATF2 deficiency leads to
dysregulated JNK and p38 activities. One possibility is that ATF2
mutant neurons display an aberrant response to stress conditions
such as oxidative stress, or inflammatory stress, for which ATF2
may have important roles [63]. Stressed neurons may lead to high
levels of active stress kinases which may be dangerous to cell
survival. Alternatively, a more direct role for ATF2 in stress kinase
regulation was uncovered in our analysis of ATF2 functions for the
survival of liver cell precursors [13]. Here, loss of functional ATF2,
and its closest homologue ATF7, resulted in hyperactive p38
kinase and p38-induced apoptosis in the embryonic liver cells
concomitant with reduced levels of members of the DUSP family
of MAP kinase phosphatases. A similar defect in a negative
feedback regulation of stress kinases may operate in ATF2 single
mutant mice in specific regions of the developing brain. In
conclusion, our observations demonstrate that MAP kinase
activities require tight control during neuronal development and
that ATF2 is both a target and a regulator of these activities.
Materials and Methods
Generation of ATF2 mutant transgenic mice
Atf22/2, Atf2AA, and Atf2f/f mice were reported previously [13].
Atf2Dneuron mice were generated by crossing Atf2f/+ nestin-Cre mice
with Atf2f/f mice. Atf2Depiblast mice knockouts were produced by
crossing Atf2f/+ meox2-Cre mice with Atf2f/f mice. The offspring
genotypes were approximately of the expected frequency for all
possible allele combinations. All animal work was approved by the
Paterson Institute Ethical Review Committee and was performed
within the limits of a license granted by the Home Office
according to the Animals (Scientific Procedures) Act 1986.
Immunohistochemistry
Brains were dissected out of embryos and were fixed overnight
in 4% paraformaldehyde or frozen. Six-micron sections were
produced from paraffin-embedded PFA-fixed samples or sucrose-
embedded frozen samples. Immunohistochemistry was performed
according to the antibody specification. For some antibodies,
antigen retrieval was carried out in citrate buffer pH 6. For whole-
mount immunostaining, E12.5 embryos were fixed in 100%
methanol for two hours at 4uC and rehydrated in methanol/PBS/
0.1% Tween-20 series. Embryos were washed in TBS pH 7.55/
0.4% Triton X-100 and bleached by treatment with 2% H2O2 for
10 min. Embryos were then blocked in 5% non fat dry milk,
incubated overnight with neurofilament M antibodies and
revealed with Envision DAKO kit (Dako, K3955). Whole mount
in situ hybridization was performed as previously described [64].
Krox20 and Hoxb3 RNA probes were kindly provided by Dr. F.
Mechta-Grigoriou [65]. Sudan black B staining was performed
according to histological techniques as described [66]. Transmis-
sion electron microscopy was performed according to standard
procedures [67].
Antibodies
Commercial primary antibodies used were anti-phospho-ATF2
(Thr71) (#9221, dilution 1:100), anti-phospho-p44/p42MAPK
(Thr202/Tyr204, #4376, 1:100), anti-phospho-p38 MAPK
(Thr180/Tyr182, #9211, 1:100), anti-phospho-JNK (Thr183/
Tyr185, #9251, 1:100), anti-c-Jun (#9165, 1:80) and anti-
cleaved-caspase3 (Asp175, #9661, 1:200), anti-Bim (C34C5,
1:1000) all from Cell Signaling; anti-phospho-c-Jun (Ser73,
#3502, Biovision, 1:80); Nkx2.2, NF-M, Pax6, Pax7, Islet-1,
Lim3 antibodies (concentrates, 1:100) all from Developmental
Studies Hybridoma Bank (Iowa, USA); anti-tyrosine hydroxylase
(AB152, 1:400), anti-choline acetyltransferase (AB144, 1:100), anti-
GFAP (AB5804, 1:500), anti-calbindin D-28K (AB1778, 1:500) all
fromMillipore; anti-5-HT (#11161, Progen, 1:50); rabbit anti-Islet-
1 (ab26122, Abcam, 1:1000); anti-b-tubulin (Tuj1, MRB-435S,
Covance); anti-MKP1 (sc-370), anti-MKP5 (sc-47663), anti-phos-
pho-Bcl2 (Ser70, sc-47663) all from Santa Cruz Biotechnology.
Anti-phospho-NF-M (clone RMO8, 1:10) and anti-phospho-NF-H
(clone RMO24.9, 1:10) were a kind gift from Beat Riederer,
(DBCM, University of Lausanne). ATF2-DBD antibodies were
raised in rabbit against the peptide epitope RRAANEDPDEKRRK
(BioGenes, Berlin) and affinity purified (Pharmacia).
Cell counts
All counting and measurements were performed using the
Neurolucida software. Isl-1+ hypoglossal cells were counted on
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transverse sections through the caudal medulla (r7–r8) of E12.5
and E14.5 heterozygous (n = 16 sections from two E12.5 embryos
and n= 13 sections from two E14.5 embryos) and Atf22/2 mutants
(n = 24 sections from three E12.5 embryos and n= 15 sections
from two E14.5 embryos). E18.5 hypoglossal neurons were
counted based on 5-HT immunostaining of 5-HT terminals in
this nucleus as previously described [68] combined with
hematoxylin staining of individual nuclei (n = 13 sections from
two Atf2+/2 embryos and n=233 sections from four Atf22/2
embryos). Cleaved Caspase 3+ apoptotic cell bodies were counted
on transverse sections of E11.5 Atf2+/2 and Atf22/2 (n = 12
sections from three embryos for each genotype) and immuno-
stained with Lim3 to identify abducens motoneurons.
RNA and protein analysis
Protein was isolated from E14.5 hindbrains by extraction into
Cytobuster reagent (Novagen). RNA was isolated from frozen
E14.5 hindbrain sections using laser micro-dissection (LMD6000,
Leica). Sections were immunostained with Isl-1 antibodies to
identify motoneuron nuclei. Total RNA was isolated using
RNAqueous-Micro Kit (Ambion). RNA quality was verified using
RNA Nano Chips (Agilent) on Agilent 2100 Bioanalyser. RNA
was amplified using Ovation Pico WTA System (Nugen). Real-
time quantitative PCR assays were performed on ABI7900
(Applied Biosystems) using Jumpstart TaqReady Mix (Sigma)
and gene specific primers and probes (Universal Probe Library,
Roche).
Supporting Information
Figure S1 Hindbrain defects in E18.5 brain of ATF2
mutant embryos. (A) Efficient deletion of Atf2 floxed alleles by
neuronal-specific Cre recombinase expression as revealed by HRP
immunostaining using an antibody against the DNA-binding
domain of ATF2. ATF2 is efficiently expressed in the hippocam-
pus and the brainstem of Atf2f/+;nestin-Cre but is completely absent
in Atf2f/f;nestin-Cre. (B) HRP immunostaining of calbindin in
sagittal sections of cerebellum reveals lack of foliation and laminar
distribution in Atf2AA and Atf2Dneuron mice compared to their
control littermates. Bar: A, B, 250 mm.
(TIF)
Figure S2 Epitope specificity of ATF2 antibodies. (A-D’)
E11.5 transversal brainstem sections at the level of the facial
branchiomotor neurons were fluorescently stained with antibodies
against Isl-1 (green, A–D) and phospho-ATF2 at Thr71 (ATF2-
PT71, red, A’, B’) or the DNA binding domain of ATF2 (ATF2-
DBD, red, C’, D’). ATF2-PT71 positive signals were found in
Atf2+/AA (A’) but not in Atf2AA neurons (B’). ATF2-DBD positive
signals were found in Atf2+/+ (C’) but not in Atf22/2 neurons (D’).
Bar: 100 mm.
(TIF)
Figure S3 Hyperphosphorylation of JNK and c-Jun in
ATF2 mutant motoneurons. (A–D) Hyperphosphorylation of
JNK (green; Isl-1, red) in hypoglossal (h) and vagal (v)
motoneurons in Atf2AA embryos compared to control Atf2+/AA
littermate at E12.5 (A and B) and E14.5 (C and D). (E–H)
Hyperphosphorylation of JNK (E and F) and c-Jun (G and H)
(green; Isl-1, red) in Atf22/2 facial branchiomotor neurons at
E12.5. (I–L) Hyperphosphorylation of JNK (green, Isl-1 in red) in
Atf22/2 C1 motoneurons of the spinal cord (arrowheads) at E13.5
(I and J) and E15.5 (K and L). (M–P) Fluorescence immunostain-
ing of hypoglossal motoneurons against P-ERK1/2 (Thr202/
Tyr204) (green) and Isl-1 (red). No differences were observed
between Atf22/2 and Atf2+/2 embryos at E12.5 (M and N) or
E14.5 (O, P). Bar: 100 mm.
(TIF)
Figure S4 Reduced expression of c-Jun in Atf22/2
hindbrain neurons. RNA in situ hybridization of c-Jun mRNA
at E14.5. Overall signal intensity is stronger in Atf2+/+ compared
to Atf22/2. Notably, staining of the hypoglossal nucleus (arrows) is
markedly reduced in Atf22/2. Bar: 100 mm.
(TIF)
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